Clinical Trial Detail

NCT ID NCT04051996
Title GLASDEGIB (PF-04449913) WITH TWO STANDARD DECITABINE REGIMENS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Yale University
Indications

acute myeloid leukemia

Therapies

Decitabine + Glasdegib

Age Groups: adult senior

Additional content available in CKB BOOST